Rituparna Das

Also affiliated with Homi Bhabha National Institute, Moderna Therapeutics (United States)

MedicineAgricultural and Biological SciencesBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 12 papers. Top paper: “Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial”.

Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac188

N/A

0.686DataRank · unranked

21 citations

Lindsey R. Baden, Brandon Essink, David C. Montefiori, Adrian McDermont, Richard Rupp +19 more

Immune correlates analysis of mRNA-1345 RSV vaccine efficacy clinical trial

Nature Communications(2025)10.1038/s41467-025-61153-x

N/A

0.477DataRank · unranked

23 citations

Jiejun Du, Lan Lan, Archana Kapoor, Gonzalo Perez Marc, Gilberto Jimenez +13 more

Who to Boost When: The Effect of Age and Dosing Interval on Delta and Omicron COVID-19 Incidence in the Open-label Phase of the COVE Trial

Open Forum Infectious Diseases(2024)10.1093/ofid/ofae689

N/A

0.444DataRank · unranked

8 citations

Xiaowei Wang, Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, Peter B. Gilbert +13 more

Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial

Nature Communications(2024)10.1038/s41467-024-52348-9

N/A

0.428DataRank · unranked

9 citations

Youyi Fong, Jonathan Fintzi, Eric Chun‐Pu Chu, Holly Janes, Avi Kenny +37 more

Safety and Immunogenicity of an mRNA-1273 Booster in Children

Clinical Infectious Diseases(2024)10.1093/cid/ciae420

N/A

0.420DataRank · unranked

8 citations

C. Buddy Creech, Christina A. Rostad, Quito Osuna Carr, Liberation de Leon, M Dietrich +22 more

Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccines

Cell Reports(2025)10.1016/j.celrep.2025.115986

N/A

0.310DataRank · unranked

6 citations

Abigail M. Jackson, Jeffrey Copps, Monica L. Fernández‐Quintero, Jonathan L. Torres, Sara T. Richey +15 more

Evaluation of Cellular Immune Responses After mRNA-1273 Vaccination in Children 6 Months to 11 Years of Age

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf144

N/A

0.304DataRank · unranked

6 citations

James D. Campbell, Grant Paulsen, Sabine Schnyder Ghamloush, W. Xu, Lingyi Zheng +7 more

1939. Who to Boost When: An Analysis of Dosing Interval and Age on COVID-19 Outcomes in the COVE Trial During the Delta and Omicron Waves

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad500.2470

N/A

0.208DataRank · unranked

3 citations

Xiaowei Wang, Peter B. Gilbert, Lindsey R. Baden, Hana M. El Sahly, Brandon Essink +10 more

Associations of Immunogenicity and Reactogenicity After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine in the COVE and TeenCOVE Trials

Clinical Infectious Diseases(2022)10.1093/cid/ciac780

N/A

0DataRank · unranked

7 citations

Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, Kashif Ali, Gary Berman +10 more

Long-term safety and efficacy of COVE study open-label and booster phases

Research Square(2024)10.21203/rs.3.rs-3900939/v1

N/A

0DataRank · unranked

0 citations

Hana M. El Sahly, Brandon Essink, Dean Follmann, Gregory Hachigian, Cynthia Strout +19 more

Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccines

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.12.11.628030

N/A

0DataRank · unranked

0 citations

Abigail M. Jackson, Jeffrey Copps, Monica L. Fernández‐Quintero, Jonathan L. Torres, Sara T. Richey +15 more

Distinct immunologic changes in vivo following combination versus individual PD-1 or CTLA-4 checkpoint blockade in human cancer

Journal for ImmunoTherapy of Cancer(2014)10.1186/2051-1426-2-s3-o7

N/A

0DataRank · unranked

0 citations

Rakesh Verma, Mario Sznol, Chandra Sekhar Boddupalli, Scott Gettinger, Harriet Kluger +3 more